CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Thomas Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Thomas Pharmaceuticals Ltd
750 State Route 34
Phone: (732) 441-7700p:732 441-7700 Matawan, NJ  07747-4600  United States

On 11/6/2015, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Thomas Pharmaceuticals Ltd for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
Thomas Pharmaceuticals, Ltd. (Thomas Pharmaceuticals) develops and markets over the counter non-prescription healthcare products. Acid+All is the Company’s first product. Acid+All is a calcium-enriched, sugar free, anti-gas antacid tablet. The Company was a wholly owned subsidiary of iVoice, Inc. (iVoice). As of December 31, 2008, the Company did not produce any products.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200912/31/2008YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director MarkMeller 55 5/22/2008 5/22/2008
Director Frank V.Esser 72 1/6/2006 1/6/2006

Business Names
Business Name
Small Cap Advisors, Inc.
Thomas Pharmaceuticals, Ltd.

General Information
Number of Employees: 1 (As of 12/31/2007)
Outstanding Shares: 541,810,617 (As of 9/30/2009)
Shareholders: 755
Stock Exchange: OTC
Federal Tax Id: 203954826


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023